New hepatitis viruses

Journal of Hepatology

Volumn 25, Issue 2, 1996, Pages 239-247

  Heringlake, Stefan ^a   Tillmann, Hans L ^a   Manns, Michael P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; HEPATITIS; HEPATITIS G VIRUS; HEPATITIS VIRUS; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030220377     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80081-X     Document Type: Review

References (73)

1. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
2. Alter H.J., Purcell R.H., Shih J.W., Melpolder J.C., Houghton M., Choo Q.L., Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med. 321:1989;1494-1500.
3. Weiner A.J., Kuo G., Bradley D.W., Bonino F., Saracco G., Lee C., Rosenblatt J., Choo Q.L., Houghton M. Detection of hepatitis C viral sequencies in non-A, non-B hepatitis. Lancet. 335:1990;1-3.
4. Hammel P., Marcallin P., Martinot-Peignoux M., Pham B.N., Degott C., Level R., Lefort V., Benhallem A., Erlinger S., Benhamou J.P. Etiology of chronic hepatitis in France: predominant role of hepatitis C virus. J Hepatol. 21:1994;618-623.
5. Reyes G.R., Purdy M.A., Kim J.P., Luk K.C., Young L.M., Fry K.E., Bradley D.W. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science. 247:1990;1335-1339.
6. Bradley D.W. Enterically-transmitted non-A, non-B hepatitis. Br Med Bull. 46:1990;442-461.
7. Velazquez O., Stetler H.C., Avila C., Ornelas G., Alvarez C., Hadler S.C., Bradley D.W., Sepulveda J. Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986-87. JAMA. 263:1990;3281-3285.
8. Deka N., Sharma M.D., Mukerjee R. Isolation of the novel agent from human stool samples that is associated with sporadic non-A, non-B hepatitis. J Virol. 68:1994;7810-7815.
9. Alter H.J., Bradley D.W. Non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC). Semin Liver Dis. 15:1995;110-120.
10. Sherlock S., Dooley J. 9th Edn. Disease of the Liver and Biliary System. 1993;Blackwell Scientific Publications, Oxford.
11. Buti M., Jardi R., Rodriguez-Frias F, Quer J., Esteban R., Guardia J. Etiology of acute sporadic hepatitis in Spain: the role of hepatitis C and E viruses. J Hepatol. 20:1994;589-592.
12. Tassopoulos N.C., Hatzakis A., Delladetsima I., Koutelou M.G., Todoulos A., Miriagou V. Role of hepatitis C virus in acute non-A, non-B hepatitis in Greece. A 5-year prospective study. Gastroenterology. 102:1992;969-972.
13. Tassopoulos N.C., Krawczynski K., Hatzakis A., Katsoulidou A., Delladetsima I., Koutelou M.G., Trichopoulos D. Case report: role of hepatitis E virus in the etiology of community-acquired non-A, non-B hepatitis in Greece. J Med Virol. 42:1994;124-128.
14. Kodali V.P., Gordon S.C., Silverman A.L., McCray D.G. Cryptogenic liver disease in the United States: further evidence for non-A, non-B, non-C hepatitis. Am J Gastroenterol. 89:1994;1836-1839.
15. Tibbs C., Williams R. Viral causes and management of acute liver failure. J Hepatol. 22:1995;68-73. (suppl. 1).
16. Hoofnagle J.H., Carithers R.L., Shapiro C., Ascher N. Fulminant Hepatic Failure: Summary of a Workshop. Hepatology. 21:1995;240-252.
17. Wright T.L. Etiology of fulminant hepatic failure: is another virus involved? Gastroenterology. 104:1993;640-653.
18. O'Grady J.G., Portmann B., Williams R. Fulminant hepatic failure. Schiff L., Schiff E.R. 7th Edn. Diseases of the Liver. 1077-1090:1993;Lippincott Company, Philadelphia.
19. Sallie R., Tibbs C., Silva A.E., Sheron N., Eddleston A., Williams R. Detection of hepatitis E but not C in sera of patients with fulminant NANB hepatitis. Hepatology. 14:1991;68A.
20. Sallie R., Silva A.E., Purdy M., Smith H., McCaustland K., Tibbs C., Portmann B., Eddleston A., Bradley D., Williams R. Hepatitis C and E in non-A non-B fulminant hepatic failure: a polymerase chain reaction and serological study. J Hepatol. 20:1994;580-588.
21. Romeo R., Pol S., Demeret C., Thiers V., Kremsdorf D., Cuillerier E., Berthelot P., Brechot C. Evidence of non-A, non-B, non-C infection in chronic hepatitis by polymerase chain reaction testing for hepatitis B and C viruses. J Hepatol. 22:1995;125-129.
22. Gordon F.D., Anastopoulos H., Khettry U., Loda M., Jenkins R.L., Lewis W.D., Trey C. Hepatitis C infection: a rare cause of fulminant hepatic failure. Am J Gastroenterol. 90:1995;117-120.
23. Liang T.J., Jeffers L., Reddy R.K., Silva M.O., Cheinquer H., Findor A., DeMedina M., Yarbough P.O., Reyes G.R., Schiff E.R. Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses. Gastroenterology. 104:1993;556-562.
24. Wright T.L., Hsu H., Donegan E., Feinstone S., Greenberg H., Read A., Ascher N.L., Roberts J.P., Lake J.R. Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med. 115:1991;111-112.
25. Hanau C., Munoz S.J., Rubin R. Histopathological heterogeneity in fulminant hepatic failure. Hepatology. 21:1995;345-351.
26. Liang T.J., Jeffers L., Findor A, Reddy R, Silva M, De Medina M, Schiff E. Lack of evidence of hepatitis C virus infection in non-A, non-B fulminant and late-onset hepatic failure. Hepatology. 14:1991;129A.
27. Mutimer D, Shaw J, Neuberger J, Skidmore S, Martin B, Hubscher S, McMaster P, Elias E. Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis. Gut. 36:1995;433-436.
28. Chu CM, Sheen IS, Liaw YF. The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B. Gastroenterology. 107:1994;189-195.
29. Yoshiba M, Dehara K, Inoue K, Okamoto H, Mayumi M. Contribution of hepatitis C virus to non-A, non-B fulminant hepatitis in Japan. Hepatology. 19:1994;829-835.
30. Wu JC, Chen CL, Hou MC, Chen TZ, Lee SD, Lo KJ. Multiple viral infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: application and limitations of the polymerase chain reaction. Hepatology. 19:1994;833-840.
31. Fagan EA, Ellis DS, Portmann B, Tovey GM, Williams R, Zuckerman AJ. Microbial structures in a patient with sporadic non-A, non-B fulminant hepatitis treated by liver transplantation. J Med Virol. 22:1987;189-198.
32. Fagan EA, Ellis DS, Tovey GM, Lloyd G, Portmann B, Williams R, Zuckerman AJ. Toga-like virus as a cause of fulminant hepatitis attributed to sporadic non-A, non-B. J Med Virol. 28:1989;150-155.
33. Fagan EA, Ellis DS, Tovey GM, Smith HM, Portmann B, Tan KC, Zuckerman AJ, Williams R. Toga virus-like particles in acute liver failure attributed to sporadic non-A, non-B hepatitis and recurrence after liver transplantation. J Med Virol. 38:1992;71-77.
34. Deinhardt F, Holmes AW, Capps RP, Popper H. Studies on the transmission of human viral hepatitis to marmoset monkeys. J Exp Med. 125:1967;673-687.
35. Parks WP, Melnick JL, Voss WR, Singer DB, Rosenberg HS, Alcott J, Casazza AM. Characterization of marmoset hepatitis virus. J Infect Dis. 120:1969;548-559.
36. Almeida JD, Deinhardt F, Holmes AW, Peterson DA, Wolfe L, Zuckerman AJ. Morphology of the GB hepatitis agent. Nature. 261:1976;608-609.
37. Karayiannis P, Petrovic LM, Fry M, Moore D, Enticott M, McGarvey MJ, Scheuer PJ, Thomas HC. Studies of GB hepatitis agent in tamarins. Hepatology. 9:1989;186-192.
38. Lisitsyn N, Lisitsyn N, Wilger M. Cloning the difference between two complex genomes. Science. 259:1993;946-951.
39. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpes virus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 266:1994;1865-1869.
40. Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, Muerhoff AS, Erker JC, Buijk SL, Chalmers ML, Van Sant CL, Mushahwar IK. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA. 92:1995;3401-3405.
41. Muerhoff AS, Leary TP, Simons JN, Pilot-Matias TJ, Dawson GJ, Erker JC, Chalmers ML, Schlaudr GG, Desai SM, Mushahwar K. Genomic organization of GB viruses A and B: two new members of the flaviviridae associated with GB agent hepatitis. J Virol. 69:1995;5621-5630.
42. Schlauder GG, Dawson GJ, Simons JN, Pilot-Matias TJ, Gutierrez RA, Heynen CA, Knigge MF, Kurpiewski GS, Buijk SL, Leary TP, Muerhoff AS, Desai SM, Mushahwar IK. Molecular and serologic analysis in the transmission of the GB hepatitis agents. J Med Virol. 46:1995;81-90.
43. Pilot-Matias TJ, Pratt SD, Lane BC. High-level synthesis of the 12 kDa human FK 506-binding protein in Escherichia coli using translational coupling. Gene. 128:1993;219-225.
44. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar IK. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med. 1:1995;564-569.
45. Stevens CE, Taylor PE, Pindyck J, Choo QL, Bradley DW, Kuo G, Houghton M. Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors. JAMA. 263:1990;49-53.
46. Cheng C, Hsueh YS, Lumeng L. Detection of hepatitis C virus by polymerase chain reaction in HCV EIA-positive sera obtained from volunteer blood donors. Hepatology. 12:1990;876.
47. Chemello L, Cavaletto D, Pontisso P, Bortolotti F, Donada C, Donadon V, Frezza M, Casarin P, Alberti A. Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease. Hepatology. 17:1993;179-182.
48. Marcellin P, Martinot-Peignoux M, Hammel P, Degott C, Aumont P, Erlinger S, Benhamou JP. Chronic non-A, non-B, non-C hepatitis in France. Gastroenterology. 104:1993;949A. (suppl).
49. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet. 346:1995;1131-1132.
50. Takacs M, Berencsi G, Mezey I, Brojnas J, Barcsay E, Garamvolgyi E, Hutter E, Ferenczi E, Pipirasz E, Hollos I. Detection of transfusion-associated hepatitis caused by non-A, non-B, non-C flavivirus. Acta Microbiol Immunol Hung. 41:1994;83-89.
51. Hess G, Hadziyannis SJ, Wages J, Karayiannis P, Piatek M, Vrettou H, Horsch A, Kim JP, Foung S, Thomas HC. The prevalence of a new flavivirus (HGV) in patients with liver disease and in groups at risk of exposure to blood and blood products. Basel Liver Week. 1995;. Abstract No: 174.
52. Muerhoff AS, Leary TP, Simons JN, Dawson GJ, Pilot-Matias TJ, Schlauder GG, Desai SM, Mushahwar IK. The GB hepatitis viruses: molecular cloning, characterization and classification. Basel Liver Week. 1995;. Abstract No: 177.
53. Kim JP, Linnen J, Wages J, Fry K, Zhang-Keck ZY, Young L, Gallagher P, Shih J, Krawczynski K, Nakasuji Y, Alter M, Hyams C, Margolis H, Bradley D, Alter H, Foung S. Hepatitis G virus (HGV), a new hepatitis virus associated with human hepatitis. J Hepatol. 23:1995;78. (suppl 1).
54. Hadziyannis SJ, Dawson GJ, Vrettou E, Gioustozi A, Schlauder G, Desai S. Infection with the novel GB-C virus in multiply transfused patients and in various forms of chronic liver disease. Hepatology. 22:1995;218A.
55. Kim JP, Linnen J, Wages J, Shih J, Nakatsuji Y, Fry K, Zhang-Keck ZY, Young L, Gallagher P, Krawczynski K, Ismay S, Hyams C, Lifson J, Alter M, Margolis H, Foung S, Bradley D, Alter H. Identification of a new hepatitis virus (HGV) and its implication in post-transfusion hepatitis. Hepatology. 22:1995;218A.
56. Berenguer M, Terrault NA, Piatak M, Yun A, Kim JP, Lake JR, Roberts JP, Ascher NL, Wright TL. Hepatitis G virus (HGV) in hepatitis C virus (HCV) infection following liver transplantation (OLTx). Hepatology. 22:1995;151A.
57. Fry KE, Linnen J, Zhang-Keck ZY, Fung K, Hoover C, Fernandez J, Kim JP. Sequence analysis of a new RNA virus (hepatitis G virus, HGV) reveals a unique virus in the flaviviridae family. Hepatology. 22:1995;181A.
58. Linnen JM, Zhang-Keck ZY, Fung K, Wages J, Hoover C, Piatak M, Fernandez J, Mo D, Foung SK, Fry KE, Kim JP. Genetic organization and sequence variation of the hepatitis G virus (HGV). Hepatology. 22:1995;181A.
59. Zhang YF, Zhang-Keck ZY, Linnen J, Fung K, Lim MY, Huang CC, Belyaev A, Yarbough PO, Lifson J, Kim JP. Proteolytic processing of the polyprotein of a newly discovered human RNA virus associated with hepatitis. Hepatology. 22:1995;181A.
60. Belyaev AS, Chong S, Wages J, Hoover C, Linnen J, Kim JP. Model of translocation and cleavage of the hepatitis G virus polyprotein. Hepatology. 22:1995;182A.
61. Jeffers LJ, Piatak M, Bernstein DE, Reddy KR, Lifson JD, Yun A, Coelho-Little E, de Medina M, Kim JP, Schiff ER. Hepatitis G virus infection in patients with acute and chronic liver disease of unknown etiology. Hepatology. 22:1995;182A.
62. Nakatsuji Y, Shih JWK, Tanaka E, Wages J, Kiyosawa K, Kim JP, Alter HJ. Prevalence of hepatitis G virus (HGV) in Japan. Hepatology. 22:1995;182A.
63. Hadziyannis S, Wages J, Kim JP, Karayannis P, Hess G, Piatak M, Lifson J, Vrettou H, Horsch A, Foung S, Thomas HC. Frequency of viremia with a new hepatitis virus (HGV) in patients with liver disease and in groups at high risk of exposure to blood and blood products. J Hepatol. 23:1995;78A. (suppl. 1).
64. Linnen J, Wages J, Zhang-Keck ZY, Frey Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziyannis S, Karayannis P, Fung K, Nakatsuji Y, Shih JW, Young L, Piatak M, Hoover C, Fernandez J, Chen S, Zou JC, Morris T, Hyams KC, Ismay S, Lifson JD, Hess G, Foung SK, Thomas H, Bradley D, Margolis H, Kim JP. Molecular clonin and disease association of hepatitis G virus: a transfusion-transmissable agent. Science. 271:1996;505-508.
65. Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, Murayama N, Inoue T, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med. 334:1996;1485-1490.
66. Aikawa T, Sugai Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med. 334:1996;195-196.
67. Feucht HH, Zollner B, Polywka S, Laufs R. Vertical transmission of hepatitis G. Lancet. 347:1996;615.
68. Kekule AS, Nitschko H, Frosner G, Zachoval R, Brodl U, Mairhofer H, Schmalbauer E. Hepatitis GB virus: coinfection with HCV, response to interferon and possible association with fulminant hepatitis. IX Triennial International Symposium on Viral Hepatitis and Liver Disease. 1996;. Abstract no. 143.
69. Riffelmann M, Viazov S, Lange R, Kekule AS, Nitschko H, Erhard J, Frosner G, Eigler FW, Roggendorf M. Detection of GB-C virus RNA by nested RT-PCR in patients with fulminant hepatitis. IX Triennal International Symposium on Viral Hepatitis and Liver Disease. 1996;. Abstract no. C210.
70. Moaven L, Angus P, Bowden DS, Kim J, Yun A, McCaw R, Revill P, Locarnini SA. No apparent association of hepatitis G virus with non A-E fulminant hepatitis in a small cohort study. IX Triennial International Symposium on Viral Hepatitis and Liver Disease. 1996;. Abstract no C210.
71. Sallie R, Shaw J, Mutimer D. GBV-C virus and fulminant hepatic failure. Lancet. 347:1996;1552.
72. Pilot-Matias TJ, Muerhoff AS, Simons JN, Leary TP, Buijk SL, Chalmers ML, Erker JC, Schlauder GG, Dawson GJ, Desai SM, Mushahwas IK. Identification of antigenic regions in the GB hepatitis viruses GBV-B and GBV-C. J Med Virol. 48:1996;320-338.
73. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, Schlauder GG, Dawson GJ, Desai SM, Mushahwar IK. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human hepatitis. J Med Virol: 48: 60-7.